Vice President, Worldwide Cell Therapy Medical, Autoimmune

Working with Us
Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us.

Position Summary

We are seeking a dynamic and visionary Worldwide Medical Lead to oversee our Cell Therapy Autoimmune programs. This role involves shaping and executing the global medical strategy across disease areas within rheumatology and neurology as well providing oversight of other areas of development for our growing Cell Therapy portfolio.  This leader will ensure scientific excellence and collaborate closely with the US Cell Therapy Medical organization as well as cross-functional teams across the enterprise, including Research & Development, Commercial, and Market Access, to maximize the value of our cell therapy portfolio in these disease settings. 

Key Responsibilities

Key Responsibilities include but are not limited to the following: 

 Strategic Leadership:

• Lead the teams to develop and execute the global medical strategies across Autoimmune diseases for Cell therapy portfolio, aligning with organizational goals and patient needs
• Anticipate and respond to dynamic market landscapes, including scientific, regulatory, and competitive challenges, ensuring a leadership position in the global immunology market
• Partner with stakeholders to ensure launch readiness
• Collaborate with R&D, Commercial, and Market Access teams to shape pipeline and portfolio strategies for our early assets that deliver life-changing therapies to patients
• Partner with cross-functional teams to ensure evidence generation efforts support regulatory submissions, reimbursement decisions, and market access strategy

Portfolio Impact and Innovation:

• Identify unmet needs, market trends, and opportunities for new product development
• Oversee differentiation strategies and signal-seeking initiatives to expand the pipeline and identify transformative therapeutic opportunities
• Shape early development strategy and contribute to trial designs and recruitment
• Ensure appropriate access for patients across US and international markets

Team Accountability:

• Lead AIMs (Asset Integrated Medical Teams) to ensure our strategy is co-created with the markets and that asset strategies reflect the needs of our countries while driving top market performance and support
• Partner closely with the Immunology organization as well as the Cell Therapy Commercial team

Operational Excellence and Outcomes:

• Lead a high-performing, inclusive, and diverse team of medical and scientific professionals, fostering a culture of accountability, collaboration, and empowerment to achieve exceptional results
• Champion organizational efficiency and agility by implementing streamlined processes that enable seamless global execution of strategic programs, initiatives, and high-impact launches
• Leverage advanced digital capabilities and data-driven tools to optimize decision-making, enhance stakeholder engagement, and provide actionable insights that shape medical and business strategies
• Establish and maintain robust systems to ensure a relentless focus on measurable outcomes across all medical activities, tracking and evaluating performance metrics to drive sustained impact, operational excellence, and continuous improvement

External Leadership and Influence:

• Serve as the global medical face of Cell Therapy in Autoimmune Diseases, representing the company with key external stakeholders, including regulatory agencies, academic and community institutions, medical organizations, population decision-makers, and patient advocacy groups
• Lead efforts to strengthen the company’s reputation as the partner of choice in the cell therapy space by advancing our commitment